Jazz Pharmaceuticals Presents Data for the Phase 3 TONES 2 Study of JZP-110 in Patients with Excessive Sleepiness Associated with Narcolepsy by Carolyn Helms | Jun 6, 2017 | Portfolio News
Zavante Therapeutics Presents Positive Results From NIH-Sponsored ZOLYD™ Phase 1 Trial At ASM Microbe 2017 Meeting by Carolyn Helms | Jun 5, 2017 | Portfolio News
Akebia Prevails in Two Additional European Patent Disputes by Carolyn Helms | Jun 5, 2017 | Portfolio News
Collegium Announces Additional Managed Care Coverage for Xtampza ER for Medicare Part D Patients by Carolyn Helms | Jun 1, 2017 | Portfolio News
Jazz Pharmaceuticals Announces FDA Acceptance of NDA for VYXEOS™ (CPX-351), an Investigational Treatment for Acute Myeloid Leukemia, with Priority Review Status by Carolyn Helms | May 31, 2017 | Portfolio News
